Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2019 Dec 17;84(1):405–415. doi: 10.1002/mrm.28129

Cerebrovascular MRI in the mouse without an exogenous contrast agent

Jérémie P Fouquet 1, Réjean Lebel 1, Lindsay S Cahill 2, John G Sled 2,3, Luc Tremblay 1, Martin Lepage 1,
PMCID: PMC7154782  PMID: 31845401

Abstract

Purpose

To assess the effect of a variety of anesthetic regimes on T2‐weighted MRI of the mouse brain and to determine the optimal regimes to perform T2‐weighted MRI of the mouse cerebrovasculature without a contrast agent.

Methods

Twenty mice were imaged with a 3D T2‐weighted sequence under isoflurane, dexmedetomidine, or ketamine‐xylazine anesthesia with a fraction of inspired oxygen varied between 10% and 95% + 5% CO2. Some mice were also imaged after an injection of an iron oxide contrast agent as a positive control. For every regime, whole brain vessel conspicuity was visually assessed and the apparent vessel density in the cortex was quantified and compared.

Results

The commonly used isoflurane anesthetic leads to poor vessel conspicuity for fraction of inspired oxygen higher or equal to 21%. Dexmedetomidine and ketamine‐xylazine enable the visualization of a significantly larger portion of the vasculature for the same breathing gas. Under isoflurane anesthesia, the fraction of inspired oxygen must be lowered to between 10% and 14% to obtain similar vessel conspicuity. Initial results on automatic segmentation of veins and arteries using the iron oxide positive control are also reported.

Conclusion

T2‐weighted MRI in combination with an appropriate anesthetic regime can be used to visualize the mouse cerebrovasculature without a contrast agent. The differences observed between regimes are most likely caused by blood‐oxygen level dependent effects, highlighting the important impact of the anesthetic regimes on cerebral blood oxygenation of the mouse brain at rest.

Keywords: T2‐weighted MRI, anesthesia, cerebral angiography, mouse brain

1. INTRODUCTION

The critical role of the vasculature in both the normal and pathological brain is increasingly drawn to our attention. In vivo imaging of the mouse cerebrovasculature has, therefore, the potential to reveal crucial information for a panoply of preclinical models.

MRI performed with T2‐weighted or susceptibility‐weighted sequences has proven to be an efficient tool to study the human cerebrovasculature without contrast agent, e.g., with susceptibility weighted imaging (SWI) protocols.1 These methods rely on the blood oxygenation level‐dependent (BOLD) effect to reveal vessels containing sufficiently high levels of deoxyhemoglobin, typically veins.

When performing rodent imaging, the oxygen saturation of hemoglobin (SO2) is heavily affected by the anesthetic regime used. It was shown in rats that the convenient and widely used isoflurane (ISO) anesthetic increases cerebral SO2 compared with α 2‐adrenoreceptors agonists anesthetics such as ketamine‐xylazine (KX) or dexmedetomidine (DEX), generating a loss of contrast between veins and cerebral tissues.2, 3, 4 However, this has not prevented the use of ISO anesthesia to study the rat cerebrovasculature without contrast agent with a T2‐weighted sequence.5, 6

There is strong evidence that modulating the anesthetic regime can lead to a good vessel conspicuity in the mouse; this was reported in the first papers on BOLD by Ogawa and collaborators.7, 8 However, to the best of our knowledge, no previous work has been published using T2‐weighted MRI (T2 MRI) without contrast agent to study the mouse cerebrovasculature. T2‐ or T2‐weighted imaging of the mouse cerebrovasculature is usually performed under ISO anesthesia with a contrast agent.9, 10, 11, 12 The contrast agent increases the complexity of the imaging experiment and can compromise vessel‐to‐tissue contrast in regions with increased vascular permeability.

In this study, we attempt to find an optimal anesthetic regime to image the vasculature of the mouse brain using T2 MRI without contrast agent. We directly compare the cerebrovascular trees obtained under ISO, KX, and DEX and assess how modifying the breathing gases modulates image contrast and vessel conspicuity. These 3 anesthetics are already used extensively for mouse imaging studies because of practical aspects such as ease of use, the possibility of repeated use, and the quick recovery of the animals (especially for ISO and DEX).13, 14, 15, 16, 17 We also acquire T2‐weighted images after an injection of an iron oxide contrast agent (Resovist) as a positive control and explore its capacity to differentiate veins and arteries in the cerebral cortex. For the first time, we present whole‐brain mouse vascular trees obtained with T2‐weighted MRI without contrast agent showing a significant fraction of the vasculature.

The results presented are of practical relevance not only for researchers interested in maximizing vessel conspicuity to study the mouse brain vasculature, but also for those interested in minimizing vessel conspicuity to remove confound during the study of other phenomena involving T2 MRI such as cerebral hemorrhage imaging, (targeted) particles of iron oxide imaging, and tracking of iron‐labeled cells. In addition, the results provide information on the effects of different anesthetics on the cerebral blood oxygenation of the mouse at rest.

2. METHODS

2.1. Anesthetic regimes

We tested a variety of anesthetic regimes. A single dosing was used for each anesthetic: for ISO, 1.5% in gas flowing at 1.5 L/min; for DEX (Precedex, Pfizer, New York, NY), initial bolus of 50 µg/kg and continuous infusion of 100 µg/kg/h started 8 min after initial bolus (injections in the caudal vein); for KX, mixture of ketamine (87 mg/kg) and xylazine (13 mg/kg) injected intraperitoneally. T2 MRI was started 30 min after the anesthetic was administered for ISO and KX. For DEX anesthesia, mild ISO anesthesia was used for cannulation and was discontinued 2 min after the DEX bolus. T2 MRI was then started 20 min after bolus injection. DEX anesthesia was reverted after imaging using a subcutaneous injection of 1 mg/kg of atipamezole (Revertor, Modern Veterinary Therapeutics, Miami, FL). Under all anesthetic regimes, mice were breathing freely in a nose cone through which a gas was administered at 1.5 L/min. We tested 3 different gases under DEX and KX anesthesia: carbogen (5% CO2 + 95% O2), 100% O2, and medical air (21% O2 + 79% N2). Under ISO anesthesia, we tested 100% O2, medical air, 18% O2, 14% O2, and 10% O2. The balance of the latter 3 gas mixes was N2. A scavenging system eliminated expiratory gases. The nose cone was carefully positioned on the animals to maintain residual expiratory gases at similar levels, although their level was not measured. Respiration rate was monitored, and mice were kept warm using a flow of air continuously adjusted at 30°C.

2.2. Animal groups

This study comprised a total of 86 imaging datasets. A total of N = 20 Balb/c mice of age 50 to 70 days were imaged with T2 MRI under different anesthetic regimes. The mice were separated in 3 groups for which the anesthetic regimes are listed in Table 1.

Table 1.

Anesthetic regimes under which the 3 animal groups of this study were imaged with the T2 MRI sequence

Group 1 (N = 6 males) Group 2 (N = 4 males and N = 4 females) Group 3 (N = 6 males)
ISO/100% O2 ISO/medical air ISO/medical air
KX/carbogen DEX/carbogen ISO/18% O2
KX/100% O2 DEX/100% O2 ISO/14% O2
KX/medical air DEX/medical air ISO/10% O2
ISO/100% O2 + Resovist    

For each group, imaging sessions were at least 1 week apart to ensure anesthetics were eliminated before the next session. The anesthetic regimes were tested in a random order, which was different for each mouse to randomize the effects of time and previous anesthesia on the results. For group 1, a last T2 MRI acquisition under ISO/100% O2 was performed 2 min after the injection of a superparamagnetic particle of iron oxide (Resovist, Schering AG, Berlin, Germany; 5.6 mg of iron/kg through a caudal vein catheter). This method (referred to as ISO/Resovist) allows to visualize a large number of vessels in the mouse brain,11, 12 thus providing a positive control for vessel detection. The investigator was not blind to anesthetic conditions. All experiments were conducted in accordance with the recommendations of the Canadian Council on Animal Care and approved by the Institutional Animal Care and Use Committee (Comité Facultaire de Protection des Animaux de la Faculté de Médecine et des Sciences de la Santé; CFPA‐FMSS). Animals were kept in standard housing conditions with 14 h/10 h light/dark cycles, water and food ad libitum, and a maximum of 4 animals per cage. Animal experiments are reported in compliance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines.

2.3. T2‐weighted MRI

T2‐weighted MRI was performed on a 7T scanner (Varian Inc., Palo Alto, CA) using a dedicated mouse head‐coil (RAPID MR International, Columbus, OH). A slab selective 3D gradient echo sequence was used with repetition time = 50 ms, echo time = 25 ms, flip angle = 15°, acquisition bandwidth = 26.2 kHz, field of view = 20 × 15 × 10 mm3, voxel size = 78.1 × 78.1 × 104.2 µm3, 2 averages and flow compensation in all directions.

2.4. Image processing and analysis

2.4.1. Whole brain vascular tree extraction

Every T2 MRI data set was zero‐filled to obtain a reconstructed isotropic 39.1 µm resolution. Inhomogeneities in image magnitude (principally caused by receive head‐coil sensitivity) were corrected using N4ITK.18 Briefly, N4ITK fits a low frequency spatially varying field to the image and divides the image by this field, reducing variations of low spatial frequencies in the measured signal. Two methods were tested to extract a whole brain vascular tree from the T2 MRI data: (1) histogram‐based thresholding of the Frangi index obtained from an anesthetic regime with high vessel conspicuity (e.g., KX/medical air) and (2) for each mouse, registering and comparing an image with high vessel conspicuity (e.g., KX/medical air) to an image with low vessel conspicuity (e.g., ISO/100% O2). For method 1, the Frangi filter19 was applied on 10 gaussian scales and the resulting index was binarized using as a threshold the maximum of the histogram plus 8 times the half width at half maximum. For method 2, ΔR2 maps were computed according to

ΔR2=lnShSl/TE

with Sh and Sl the MRI magnitude signal from the anesthetic regime with high and low vessel conspicuity, respectively, and TE the echo time.

2.4.2. Differences between anesthetic regimes

An average brain was created by registering with affine transformations 3 data sets obtained under KX/medical air anesthesia using ANTs software.20 A region of interest (ROI) was manually drawn on the cerebral cortex of the average brain for further analysis (Figure 1). The average brain and the ROI were registered to every data set using an affine transform. For every data set, the apparent vascular density (AVD) was computed in the ROI according to:

AVD=Vvasc/VROI,

where VROI is the volume of the registered ROI, and Vvasc is the volume occupied by the extracted vasculature in the ROI. For comparison between anesthetic regimes, we use the vasculature tree obtained by thresholding the Frangi index (method 1 of the previous subsection). The statistical significance of the AVD difference between anesthetic regimes was tested within each group by 1‐way analysis of variance with a Tukey correction for multiple comparisons. For group 2, the effect of sex was also tested using a 2‐way analysis of variance with a Sidak correction for multiple comparisons. The differences were assumed to be significant when P‐values < 0.05. Statistical analyses were performed with Graphpad Prism (version 7.03, Graphpad Software Inc, La Jolla, CA).

Figure 1.

Figure 1

Illustration of the ROI defined in the cortex for AVD computation and discrimination between veins and arteries. The vessels segmented in the ROI (blue) for a specific representative scan are depicted in panel A (vessels are 3D rendered in red). The ROI overlaid on magnitude image is also shown in the axial (B) and coronal (C) planes

2.4.3. Vessel size analysis

The diameter of the vessels segmented by thresholding the Frangi index was estimated using an adapted version of the local thickness algorithm available in FIJI.21, 22 The vessel masks were skeletonized using a Matlab implementation of the algorithm proposed by Lee and collaborators.23, 24 For each mouse and for every pair of anesthetic regimes, we compared corresponding matching points in the skeleton of the vasculature. To find matching points, we first registered the data sets of individual mice using ANTs and a rigid transform. Then, for every pair of regimes, we attempted to match all the skeleton points of the lower AVD regime to that of the higher AVD regime based on the distance between points, with the condition that points were within 117 µm (3 voxels). When points in the lower vascular density skeleton could be matched to more than 1 point in the higher vascular density skeleton, the average of the vessel size of matched points in the higher AVD skeleton was used for further analysis (see Figure 2). Vessel size analysis was performed on the whole brain. For every pair of regimes, we also analyzed the new vessels detected in the higher AVD regime. To be considered as a new vessel, an independent component of the higher AVD skeleton needed to include more than 90% of newly detected points.

Figure 2.

Figure 2

Various possible situations occurring when matching a point of a low AVD vessel skeleton (blue) to a high AVD vessel skeleton (red). A, The point from low AVD skeleton is matched to a unique point in the high AVD skeleton. B,C, the low AVD point is equally distant from 3 and 2 points from the high AVD skeleton, respectively. For further analysis, we match to the point from the lower AVD skeleton the average of the characteristics of the matching points in the higher AVD skeleton (for instance, the average vessel size of the multiple matched points in B and C)

2.4.4. Discrimination between veins and arteries

The proposed differentiation between veins and arteries uses an anesthetic regime that presumably reveals primarily veins, and the ISO/Resovist regime which reveals both veins and arteries. For the purposes of this study, we use the KX/medical air regime to reveal primarily veins. This choice relies on the hypothesis that arterial SO2 remains high under KX/medical air (see the Discussion section for further comments on this hypothesis). Therefore, the points of the ISO/Resovist skeleton that were matched to points in the KX/medical air skeleton (as described in the previous subsection) were assumed to be part of the venous system. On the contrary, points of the ISO/Resovist skeleton that could not be matched to points in the KX/medical air skeleton were considered to be part of the arterial system. The diameter of the venous and arterial vessels was computed by multiplying the corresponding skeleton by the vascular local thickness previously obtained. Discrimination between veins and arteries was only tested in the cortex ROI.

3. RESULTS

3.1. Effects of anesthetic regimes on T2 MRI

The contrast in T2 MRI images of the mouse brain is directly linked to the anesthetic regime (Figure 3). A striking feature is the large variation of the conspicuity of vessel‐shaped structures. Whereas DEX and KX anesthesia produce a similar apparent cortical vascular density, ISO anesthesia reveals a significantly lower AVD for an equivalent breathing gas (Figure 4). We investigated whether vessel conspicuity was also modulated by the breathing gas. For KX and DEX, medical air generates significantly higher AVD than carbogen and O2, while the latter 2 yield AVDs that are not significantly different. For ISO, using 100% O2 as a carrier leads to the detection of very few vessels (Figures 2 and 3). Reducing the O2 concentration increases the number of vessels detected: ISO/10% O2 yields significantly higher AVD than all other regimes, while ISO/14% O2 yields significantly higher AVD than ISO/medical air. Statistical tests showed no effect of the sex for the group where the 2 sexes were present (group 2; effect size of 0.4% and P = 0.55).

Figure 3.

Figure 3

Minimum intensity projection over 1.21 mm of the magnitude images obtained under all regimes tested for a representative mouse in groups 1 (A), 2 (B), and 3 (C). The conspicuity of vessels depends strongly on the anesthetic regime. Air, medical air; carbo, carbogen

Figure 4.

Figure 4

AVD computed in the cortex ROI for groups 1 (A), 2 (B), and 3 (C). Solid black lines represent individual animals. A solid gray horizontal line indicates a significant difference. The AVD measured from the mouse brain clearly depends on the anesthetic regime. Air, medical air; carbo, carbogen

3.2. Whole brain vascular tree extraction

Figure 5 shows vascular trees obtained from an anesthetic regime with high AVD (KX/medical air) by the 2 proposed methods (Frangi index and ΔR2 computation by comparison with ISO/100% O2). Both methods for vascular tree extraction yield similar vascular structures within the brain. Figure 5 also shows the vascular tree obtained with Resovist as a positive control. As reflected by the AVD within the cortex ROI (Figure 4), more vessels are present in the vascular tree obtained with Resovist. The ΔR2 computation reveals more structures at the surface of the brain than the Frangi index method. A ΔR2 value of 38 s‐1 was empirically found to be a good threshold to separate vascular structures from other brain tissues.

Figure 5.

Figure 5

3D rendering of a 3.5‐mm‐thick section of the vascular trees extracted from KX/medical air data set (A,B) and from ISO/Resovist data set (C,D). The first column (A,C) shows the Frangi index. The second column shows ΔR2 obtained by comparison with the ISO/100% O2 regime. ΔR2 = 38 s−1 was empirically found to differentiate vascular structures from other brain tissues

3.3. Discrimination between veins and arteries

Figure 6 shows an example of the veins and arteries obtained in the cerebral cortex ROI of a mouse using the proposed automatic method. The spatial distribution of veins and arteries is relatively uniform across the ROI. Some veins appear to transform into arteries at their endpoint, which most likely reflects the threshold for vessel detectability.

Figure 6.

Figure 6

Veins and arteries segmented in the cerebral cortex region of interest using the automatic method proposed. The vessels are color coded for their diameter. Some veins appear to transform into arteries at their endpoint, which most likely reflects the threshold for vessel detectability

3.4. Apparent vessel diameter comparison

Figure 7 shows how the apparent vessel diameters differ between anesthetic regimes within the whole brain. For each pair of regimes, the relative difference in apparent vessel diameter is plotted as a function of the diameter in the lower AVD regime. For group 1, the ISO/100% O2 regime was not included in the comparison because not enough vessels were detected. For most of the regime pairs, the vessels diameter seems overestimated for smaller vessels (≤60 µm). Figure 7 also shows the percentage of points belonging to new vessels in the skeleton of the regimes with higher AVD. In general, the percentage of points belonging to new vessels is larger for smaller diameters. It is also larger for regime pairs with a more important AVD difference. For instance, the KX/carbogen V ISO/Resovist pair presents the highest percentages of points belonging to new vessels.

Figure 7.

Figure 7

Relative changes in apparent diameter (left y axis; solid black line with shaded error bars) and percentage of skeleton points belonging to new vessels (right y axis; blue points) for every pair of regimes in group 1 (A; first row), group 2 (B; second row), and group 3 (C; third row). For each pair, the regime with lower AVD is indicated first over the graph. The changes in apparent vessel diameter (left y axis) are plotted as a function of the apparent diameter for the regime with lower AVD. The percentage of the skeleton belonging to new vessels (right y axis) is plotted as a function of the apparent vessel diameter for the regime with higher AVD. Values from the whole brain of all animals were pooled to create the graphs. Overall, left y axis shows that vessels appear larger in the regime detecting more vessels. Right y axis shows that it is principally small vessels in the regime detecting more vessels that are unmatched. For group 1, ISO/100% O2 is not presented because there were not enough vessels detected. Air, medical air; carbo, carbogen; Reso, Resovist; vasc., vascular

4. DISCUSSION

T2 MRI techniques without contrast agent were proven useful to detect brain vasculature in the rat5, 6 and in humans1 but, to the best of our knowledge, applications in the mouse brain have not been reported. Our results directly show that it is possible to reveal detailed vascular architecture in the mouse brain using T2 MRI without contrast agent (Figures 3, 4, 5).

KX and DEX produce a mouse vascular tree with similar AVD in the cortex ROI for equivalent breathing gas (Figure 4). For these anesthetics, even carbogen‐breathing allows for the visualization of vessels. To obtain similar vascular density under ISO anesthesia, fraction of inspired O2 must be lowered under 21%. A fraction of inspired O2 between 10% and 14% allows for the visualization of an AVD comparable to that obtained with DEX/medical air and KX/medical air. As expected, the ISO/Resovist regime generates the highest AVD.

The striking changes observed are most likely due to differences in cerebral SO2 between anesthetic regimes, deoxyhemoglobin generating most of the contrast seen in Figure 3. Similar contrast differences in T2 MRI of the rat under different anesthetic regimes have been observed and attributed to SO2 changes.3, 4 Indeed, xylazine and DEX are both α 2‐adrenergic receptors agonists that were shown to cause a significant reduction in rodents cerebral blood flow compared with ISO.2, 13, 25, 26 This is putatively caused by their cerebral vasoconstrictive27, 28 and significant bradycardic effects.29, 30 In contrast, ISO is known to have dose‐dependent vasodilatory31 and light bradycardic effects.2, 29, 32 It was also shown in dogs that DEX with low‐ISO anesthesia increases cerebral metabolic rate of oxygen compared with ISO‐only anesthesia.33 Similarly, increasing the ISO dose decreases the cerebral metabolic rate of glucose in rats.26 Taken together, these observations support the notion that SO2 in cerebral blood could be lower under DEX and KX than under ISO, especially on the venous side. This interpretation is further supported by the previous observation that, in rat, cerebral partial pressure of oxygen (pO2) was lower under KX anesthesia than under ISO anesthesia.2, 34, 35

Our results show that the widely used ISO anesthesia generates poor vessel conspicuity in the mouse when supplied in 100% O2 or medical air (Figures 2 and 3). In contrast, vessels are clearly detected under ISO anesthesia with similar gas conditions in rats.5, 6 These observations are consistent with results indicating that ISO anesthesia at a dose of 1.1‐fold the minimal alveolar concentration (mice: 1.8‐2.0%; rats: 2‐2.3%) exhausts the cerebrovascular reserve capacity in mice more effectively than in rats.13 This reduction of the cerebrovascular reserve capacity is attributed to cerebral vasodilation occurring in the resting state, which leads to an increase of the basal cerebral blood flow and possibly of the basal venous blood oxygenation. The smaller diameter of the mouse vessels can also be partly responsible for the lower number of vessels detected in this species.

Within the limits of our methodology, the interindividual variations appear lower with KX than with DEX or ISO/14% O2 and ISO/10% O2. However, ISO can be administered more easily and allows for a quick recovery, and DEX has the advantage of being easy to revert using atipamezole. The effects of KX will subside over time because it is injected intraperitoneally before imaging. This can limit the scanning time and introduce variability in the physiological parameters of the animal (including blood oxygenation) during the scan. The choice of the most appropriate anesthetic for an imaging study of the cerebrovasculature must include study‐specific information, such as the anesthetic administration method, the region(s) of interest in the brain, and the accessibility to anesthetics or breathing gases.

We tested the Frangi index and the ΔR2 methods to obtain a cerebrovascular tree from T2 MRI data sets; both yielded similar vascular structures (Figure 5). The Frangi index method requires a single data set, but small vessels at the surface of the brain are not efficiently identified due to the lack of MR signal from the skull. Vessel‐to‐tissue contrast could potentially be further improved by performing the extra postprocessing steps of SWI before application of vessel extraction algorithms. However, SWI postprocessing contains a set of tunable parameters that would need to be optimized with respect to future end‐point applications as they may introduce unwanted variability to our method.1 The second method was based on the calculation of ΔR2, which requires 2 data sets. As expected, this method is superior for the detection of vessels at the surface of the brain.5 It also generates a quantitative measurement of ΔR2 which can characterize microvasculature.36 We note that the absolute ΔR2 values reported here are to be considered with caution because the scan under ISO/100% O2 and the scans under KX/medical air or ISO/Resovist were not acquired during the same imaging session. Nonuniformity between spatial distributions of image intensity may result in inaccurate ΔR2 values.

We explored the possibility of automatically differentiating veins and arteries by comparing images acquired with and without contrast agent. Our method, conceptually similar to a manual method proposed for the cat brain,37 produces a map of veins and arteries along with their diameter (Figure 6). Such maps could be useful to explore the role of the vasculature in various pathologies or to better understand the origin of the BOLD signal in fMRI.38, 39, 40, 41 The underlying assumptions are that (1) the vessels visible under KX/medical air were principally veins with contrast generated by deoxyhemoglobin, (2) the vessels visible under ISO/Resovist were both veins and arteries with contrast generated by Resovist, and (3) the veins visible under KX/medical air regime corresponded to veins detected under ISO/Resovist.

Assumption (1) is equivalent to the one used to claim that SWI of the human brain primarily reveals veins. It supposes that arterial SO2 remains high under the anesthetic regime chosen to reveal veins. Whether it is respected in the mouse under anesthetic regimes with high AVD such as KX/medical air is an interesting open question. Based on the intracortical location of newly detected vessels, it was suggested that arterial SO2 decreases sufficiently to allow detection with T2 MRI in the rat brain under regimes similar to ISO/medical air.6 A control experiment differentiating veins and arteries would allow to directly answer this question in the mouse. This would help to further validate the automatic method presented here to separate veins and arteries. Also, it is apparent from the map presented in Figure 6 that assumption (3) does not hold perfectly for all vessels. For instance, end‐points of vessels identified as veins become arteries, which is not realistic. This instead suggests that ISO/Resovist revealed end‐points of veins that were undetectable under KX/medical air. The contrast of small veins can drop just under the detection threshold under KX/medical air. When Resovist is injected, the larger contrast enables detection of smaller portions of veins.

The apparent diameter of the detected vessels is a combination of the real vessel diameter, the magnetic susceptibility of blood, the angle between the vessel and the main magnetic field, the acquisition parameters, and the reconstruction parameters. In the tested regimes, the susceptibility of blood is affected by deoxyhemoglobin and/or by Resovist. We ran simulations with a 2‐compartments model,42 our acquisition parameters, and a conservative venous SO2 of 0.743 to estimate the diameter of the smallest detectable vessels in the anesthetic regimes with low SO2 such as KX/medical air, DEX/medical air, and ISO/10% O2. Based on the acquisition voxel volume and a detectability threshold of the parenchyma signal minus 3 times the standard deviation of the noise, we obtained a minimum detectable diameter of 14 µm for a vessel perpendicular to B0 and of 51 µm for a parallel vessel. Zero‐filling is known to increase spatial resolution and mitigate partial volume effects.44, 45, 46 The theoretical relationship giving the smallest detectable diameter while considering zero‐filling and the Frangi filter is beyond the scope of this study.

Comparing the apparent vessel diameters in different regimes clarifies the origin of the AVD differences. For instance, the apparent diameters detected in the ISO/Resovist regime were comparable to those detected in the KX/medical air regime (Figure 7A). This suggests that the susceptibility of blood is comparable in those 2 cases where the concentration of Resovist coincidentally produced a similar susceptibility than the relative concentration of deoxyhemoglobin in the vessels. The higher AVD under ISO/Resovist, therefore, results from an increase in the total length of the vasculature detected, which was assumed to be arteries. The fact that the percentage of points belonging to newly detected vessels is higher for smaller diameters for all compared pairs (Figure 7) is attributed to 2 main causes: (1) false positive vessels due to noise are more likely to be of small diameter and (2) the small vessels detected under a higher AVD regime are often just under the detectability threshold under the lower AVD regime.

Our algorithm matching vessel skeleton points is useful in automatically separating veins and arteries and provides information on how apparent vessel diameters compare between 2 anesthetic regimes. It included an approach based on the Euclidian distance between skeleton points after rigid registration of brain images under different regimes. This approach could be improved by considering whole vessel segments during matching instead of single points, and by adding more conditions for vessel matching, e.g., proximity to an expected diameter difference.

It would have been relevant to compare the results presented in this study with independent measurements of blood gases and blood oxygenation. However, blood sampling (the most common and reliable method of measurement) is difficult to perform as part of survival studies in the mouse. Terminal blood sampling would have prevented repeated MRI scans in the same animals with the detrimental consequences of introducing more important inter‐individual differences and of increasing the total number of animals required in the study. The use of a pulse oximeter could have provided the arterial SO2, although its accuracy is limited in mice.16 Similarly, it would have been relevant to measure the concentration of inspired and expired breathing gases, but these measures are not performed easily in a noninvasive way in the mouse.16

5. CONCLUSIONS

We demonstrated that it is possible to image a significant fraction of the mouse cerebrovasculature using T2 MRI without contrast agent by choosing an appropriate anesthetic regime. As opposed to results obtained in the rat, the widely used ISO anesthetic generates a poor vessel conspicuity when administered with 100% O2 or medical air. To improve vessel visualization, one can lower the fraction of inspired oxygen below 14% or use KX or DEX as an anesthetic. This is most likely due to a decrease in cerebral blood oxygenation under KX and DEX anesthesia, which is in line with results available for the rat3 and with the known physiological effects of the 3 anesthetics. We also presented groundwork for automatically segmenting veins and arteries by combining acquisitions with and without a contrast agent. It is expected that our methodology can provide vasculature maps that can be useful to study the role of vasculature in the normal or pathological mouse brain.

ACKNOWLEDGMENTS

J.P.F. is supported by a doctoral scholarship from the NSERC. M.L. is member of the FRQ‐S funded Centre de recherche du Centre hospitalier universitaire de Sherbrooke. The authors thank Mélanie Archambault and Dina Sikpa for animal handling.

Fouquet JP, Lebel R, Cahill LS, Sled JG, Tremblay L, Lepage M. Cerebrovascular MRI in the mouse without an exogenous contrast agent. Magn Reson Med. 2020;84:405–415. 10.1002/mrm.28129

Funding information

This work was supported by the Canadian Institutes of Health Research (grant number 273995).

REFERENCES

  • 1. Haacke EM, Reichenbach JR. Susceptibility Weighted Imaging in MRI : Basic Concepts and Clinical Applications, 1st edn Hoboken, NJ, USA: Wiley‐Blackwell; 2011. [Google Scholar]
  • 2. Lei H, Grinberg O, Nwaigwe CI, et al. The effects of ketamine‐xylazine anesthesia on cerebral blood flow and oxygenation observed using nuclear magnetic resonance perfusion imaging and electron paramagnetic resonance oximetry. Brain Res. 2001;913:174–179. [DOI] [PubMed] [Google Scholar]
  • 3. Ciobanu L, Reynaud O, Uhrig L, Jarraya B, Le Bihan D. Effects of anesthetic agents on brain blood oxygenation level revealed with ultra‐high field MRI Chang AYW, editor. PLoS ONE. 2012;7:e32645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Uhrig L, Ciobanu L, Djemai B, Le Bihan D, Jarraya B. Le Bihan D, Jarraya B. Sedation agents differentially modulate cortical and subcortical blood oxygenation: evidence from ultra‐high field MRI at 17.2 T. PLoS ONE. 2014;9:e100323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Huang C‐H, Chen C‐C, Siow T‐Y, et al. High‐resolution structural and functional assessments of cerebral microvasculature using 3D Gas ΔR2*‐mMRA. PLoS ONE. 2013;8:e78186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Park SH, Masamoto K, Hendrich K, Kanno I, Kim SG. Imaging brain vasculature with BOLD microscopy: MR detection limits determined by in vivo two‐photon microscopy. Magn Reson Med. 2008;59:855–865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation‐sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med. 1990;14:68–78. [DOI] [PubMed] [Google Scholar]
  • 8. Shen Y, Kou Z, Haacke EM. Susceptibility weighted imaging in rodents In: Susceptibility Weighted Imaging in MRI. Hoboken, NJ: John Wiley & Sons, Inc; 2011:649–667. [Google Scholar]
  • 9. Hamans BC, Barth M, Leenders WP, Heerschap A. Contrast enhanced susceptibility weighted imaging (CE‐SWI) of the mouse brain using ultrasmall superparamagnetic ironoxide particles (USPIO). Z Med Phys. 2006;16:269–274. [DOI] [PubMed] [Google Scholar]
  • 10. Klohs J, Baltes C, Princz‐Kranz F, et al. Contrast‐enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic ArcAβ mice. J Neurosci. 2012;32:1705–1713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Lin C‐Y, Hsu Y‐H, Lin M‐H, et al. Neurovascular abnormalities in humans and mice with Huntington’s disease. Exp Neurol. 2013;250:20–30. [DOI] [PubMed] [Google Scholar]
  • 12. Lin C‐Y, Siow TY, Lin M‐H, et al. Visualization of rodent brain tumor angiogenesis and effects of antiangiogenic treatment using 3D ΔR2‐μMRA. Angiogenesis. 2013;16:785–793. [DOI] [PubMed] [Google Scholar]
  • 13. Petrinovic MM, Hankov G, Schroeter A, et al. A novel anesthesia regime enables neurofunctional studies and imaging genetics across mouse strains. Sci Rep. 2016;6:24523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Grandjean J, Schroeter A, Batata I, Rudin M. Optimization of anesthesia protocol for resting‐state fMRI in mice based on differential effects of anesthetics on functional connectivity patterns. NeuroImage. 2014;102:838–847. [DOI] [PubMed] [Google Scholar]
  • 15. Bukhari Q, Schroeter A, Cole DM, Rudin M. Resting state fMRI in mice reveals anesthesia specific signatures of brain functional networks and their interactions. Front Neural Circuits. 2017;11:5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Tremoleda JL, Kerton A, Gsell W. Anaesthesia and physiological monitoring during in vivo imaging of laboratory rodents: considerations on experimental outcomes and animal welfare. EJNMMI Res. 2012;2:44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Gargiulo S, Greco A, Gramanzini M, et al. Mice anesthesia, analgesia, and care, part i: anesthetic considerations in preclinical research. ILAR J. 2012;53:E55–E69. [DOI] [PubMed] [Google Scholar]
  • 18. Tustison NJ, Avants BB, Cook PA, et al. N4ITK: improved N3 bias correction. IEEE Trans Med Imaging. 2010;29:1310–1320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Frangi AF, Niessen WJ, Vincken KL, Viergever MA. Multiscale vessel enhancement filtering In: Wells WM, Colchester A, Delp S, eds. Medical Image Computing and Computer‐Assisted Intervention — MICCAI’98. MICCAI 1998. Lecture Notes in Computer Science, vol 1496. Berlin: Springer, Berlin: 1998:130–137. [Google Scholar]
  • 20. Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC. A reproducible evaluation of ANTs similarity metric performance in brain image registration. NeuroImage. 2011;54:2033–2044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Hildebrand T, Rüegsegger P. A new method for the model‐independent assessment of thickness in three‐dimensional images. J Microsc. 1997;185:67–75. [Google Scholar]
  • 22. Dougherty R, Kunzelmann K‐H. Computing local thickness of 3D structures with ImageJ. Microsc Microanal. 2007;13:1678–1679. [Google Scholar]
  • 23. Lee TC, Kashyap RL, Chu CN. Building skeleton models via 3‐D medial surface axis thinning algorithms. CVGIP Graph Model Image Process. 1994;56:462–478. [Google Scholar]
  • 24. Kerschnitzki M, Kollmannsberger P, Burghammer M, et al. Architecture of the osteocyte network correlates with bone material quality. J Bone Miner Res. 2013;28:1837–1845. [DOI] [PubMed] [Google Scholar]
  • 25. Franceschini MA, Radhakrishnan H, Thakur K, et al. The effect of different anesthetics on neurovascular coupling. NeuroImage. 2010;51:1367–1377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Maekawa T, Tommasino C, Shapiro HM, Keifer‐Goodman J, Kohlenberger RW. Local cerebral blood flow and glucose utilization during isoflurane anesthesia in the rat. Anesthesiology. 1986;65:144–151. [DOI] [PubMed] [Google Scholar]
  • 27. Fukuda M, Vazquez AL, Zong X, Kim SG. Effects of the α2‐adrenergic receptor agonist dexmedetomidine on neural, vascular and BOLD fMRI responses in the somatosensory cortex. Eur J Neurosci. 2013;37:80–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Ganjoo P, Farber NE, Hudetz A, et al. In vivo effects of dexmedetomidine on laser‐Doppler flow and pial arteriolar diameter. Anesthesiology. 1998;88:429–439. [DOI] [PubMed] [Google Scholar]
  • 29. Janssen BJ, De Celle T, Debets JJ, Brouns AE, Callahan MF, Smith TL. Effects of anesthetics on systemic hemodynamics in mice. Am J Physiol Heart Circ Physiol. 2004;287:H1618–H1624. [DOI] [PubMed] [Google Scholar]
  • 30. Sinclair MD. A review of the physiological effects of alpha2‐agonists related to the clinical use of medetomidine in small animal practice. Can Vet J. 2003;44:885–897. [PMC free article] [PubMed] [Google Scholar]
  • 31. Nagase K, Iida H, Dohi S. Effects of ketamine on isoflurane‐ and sevoflurane‐induced cerebral vasodilation in rabbits. J Neurosurg Anesthesiol. 2003;15:98–103. [DOI] [PubMed] [Google Scholar]
  • 32. Constantinides C, Mean R, Janssen BJ. Effects of isoflurane anesthesia on the cardiovascular function of the C57BL/6 mouse. ILAR J. 2011;52:e21–e31. [PMC free article] [PubMed] [Google Scholar]
  • 33. Zornow MH, Fleischer JE, Scheller MS, Nakakimura K, Drummond JC. Dexmedetomidine, an alpha 2‐adrenergic agonist, decreases cerebral blood flow in the isoflurane‐anesthetized dog. Anesth Analg. 1990;70:624–630. [DOI] [PubMed] [Google Scholar]
  • 34. Liu KJ, Hoopes PJ, Rolett EL, et al. Effect of anesthesia on cerebral tissue oxygen and cardiopulmonary parameters in rats In: Nemoto EM, LaManna JC, Cooper C, eds. Oxygen Transport to Tissue XVIII. Boston, MA: Springer; 1997:33–39. [DOI] [PubMed] [Google Scholar]
  • 35. Liu KJ, Bacic G, Jack Hoopes P, et al. Assessment of cerebral pO2 by EPR oximetry in rodents: effects of anesthesia, ischemia, and breathing gas. Brain Res. 1995;685:91–98. [DOI] [PubMed] [Google Scholar]
  • 36. Troprès I, Pannetier N, Grand S, et al. Imaging the microvessel caliber and density: Principles and applications of microvascular MRI. Magn Reson Med. 2015;73:325–341. [DOI] [PubMed] [Google Scholar]
  • 37. Bolan PJ, Yacoub E, Garwood M, Ugurbil K, Harel N. In vivo micro‐MRI of intracortical neurovasculature. NeuroImage. 2006;32:62–69. [DOI] [PubMed] [Google Scholar]
  • 38. Kennerley AJ, Mayhew JE, Redgrave P, Berwick J. Vascular origins of BOLD and CBV fMRI signals: statistical mapping and histological sections compared. Open Neuroimag J. 2010;4:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Gagnon L, Sakad i  S, Lesage F, et al. Quantifying the microvascular origin of BOLD‐fMRI from first principles with two‐photon microscopy and an oxygen‐sensitive nanoprobe. J Neurosci. 2015;35:3663–3675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Kim SG, Ogawa S. Biophysical and physiological origins of blood oxygenation level‐dependent fMRI signals. J Cereb Blood Flow Metab. 2012;32:1188–1206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Vigneau‐Roy N, Bernier M, Descoteaux M, Whittingstall K. Regional variations in vascular density correlate with resting‐state and task‐evoked blood oxygen level‐dependent signal amplitude. Hum Brain Mapp. 2014;35:1906–1920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Reichenbach JR, Haacke EM. High‐resolution BOLD venographic imaging: a window into brain function. NMR Biomed. 2001;14:453–467. [DOI] [PubMed] [Google Scholar]
  • 43. Finnerty E, Ramasawmy R, O’Callaghan J, et al. Noninvasive quantification of oxygen saturation in the portal and hepatic veins in healthy mice and those with colorectal liver metastases using QSM MRI. Magn Reson Med. 2019;81:2666–2675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Bernstein MA, Fain SB, Riederer SJ. Effect of windowing and zero‐filled reconstruction of MRI data on spatial resolution and acquisition strategy. J Magn Reson Imaging. 2001;14:270–280. [DOI] [PubMed] [Google Scholar]
  • 45. Du YP, Parker DL, Davis WL, Cao G. Reduction of partial‐volume artifacts with zero‐filled interpolation in three‐dimensional MR angiography. J Magn Reson Imaging. 1994;4:733–741. [DOI] [PubMed] [Google Scholar]
  • 46. Zhu X, Tomanek B, Sharp J. A pixel is an artifact: on the necessity of zero‐filling in fourier imaging. Concepts Magn Reson Part A. 2013;42A:32–44. [Google Scholar]

Articles from Magnetic Resonance in Medicine are provided here courtesy of Wiley

RESOURCES